应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
ORR Militia Long/Short Equity ETF
交易中 11-17 10:36:35 EST
39.68
-0.26
-0.65%
最高
39.81
最低
39.68
成交量
1.12万
今开
39.72
昨收
39.94
日振幅
0.34%
总市值
3.61亿
流通市值
3.61亿
总股本
910.00万
成交额
44.70万
换手率
0.12%
流通股本
910.00万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
花旗拆解全球股市 “冷热不均”:美股靠空头回补,欧洲迎来实质新多头,亚洲空头获利丰厚
智通财经 · 11:45
花旗拆解全球股市 “冷热不均”:美股靠空头回补,欧洲迎来实质新多头,亚洲空头获利丰厚
亚盛医药APG-5918治疗R/R TCL I期数据将在2026 ASH年会口头报告,ORR为44.7%
同花顺 · 11-05
亚盛医药APG-5918治疗R/R TCL I期数据将在2026 ASH年会口头报告,ORR为44.7%
瑞银预计英镑年底升至1.38美元,英国加息预期及空头回补提供支撑
环球市场播报 · 10-30
瑞银预计英镑年底升至1.38美元,英国加息预期及空头回补提供支撑
TIL 赛道首款国产产品闯关 君赛生物诺吉仑赛注射液商业化前景几何?
新浪证券 · 10-30
TIL 赛道首款国产产品闯关 君赛生物诺吉仑赛注射液商业化前景几何?
九大研究贯通两大板块:艾帕洛利托沃瑞利单抗以全病程布局回应消化道肿瘤之困
同花顺 · 10-27
九大研究贯通两大板块:艾帕洛利托沃瑞利单抗以全病程布局回应消化道肿瘤之困
泽璟制药:2026年ESMO年会ZG006确认ORR最高91.7%
智通财经 · 10-26
泽璟制药:2026年ESMO年会ZG006确认ORR最高91.7%
CLDN18.2靶向ADC 3期研究达到双主要终点;双靶点ADC 3期结果积极……
同花顺 · 10-24
CLDN18.2靶向ADC 3期研究达到双主要终点;双靶点ADC 3期结果积极……
原油盘中涨近4%,布油冲上117美元,中东风险持续、空头回补加把火
华尔街见闻 · 10-24
原油盘中涨近4%,布油冲上117美元,中东风险持续、空头回补加把火
德银:黄金量化抛压接近“绝对耗尽”,CTA空头回补或点燃Q4反弹行情
华尔街见闻 · 10-16
德银:黄金量化抛压接近“绝对耗尽”,CTA空头回补或点燃Q4反弹行情
劲方医药-B(02595.HK):GFH375/VS-7375多项国内及海外临床研究取得积极进展,在多种 RAS 突变实体瘤中显示优秀疗效
智通财经 · 10-15
劲方医药-B(02595.HK):GFH375/VS-7375多项国内及海外临床研究取得积极进展,在多种 RAS 突变实体瘤中显示优秀疗效
交易员:布雷曼讲话引发空头回补,纽元兑美元上涨
智通财经 · 09-22
交易员:布雷曼讲话引发空头回补,纽元兑美元上涨
EGFR ex20ins赛道进入冲刺赛:伏美替尼申报一线适应症 国产双药同台竞技
新浪证券 · 09-21
EGFR ex20ins赛道进入冲刺赛:伏美替尼申报一线适应症 国产双药同台竞技
港股异动 | 映恩生物-B涨超9%,DB-1311联用Pumitamig WCLC摘要披露,一线SCLC ORR达92.3%
智通财经 · 09-14
港股异动 | 映恩生物-B涨超9%,DB-1311联用Pumitamig WCLC摘要披露,一线SCLC ORR达92.3%
创新药将迎数据催化窗口!OS、PFS、ORR还都分不清楚?速查指南来了!收藏备用
新浪基金 · 09-11
创新药将迎数据催化窗口!OS、PFS、ORR还都分不清楚?速查指南来了!收藏备用
迪哲医药:比瑞替尼II期研究发表,ORR达47.6%
智通财经 · 09-09
迪哲医药:比瑞替尼II期研究发表,ORR达47.6%
减持警报暂解?亿万富翁沃尔特质押Carvana(CVNA.US)股份 空头回补推动股价反弹逾8%
智通财经 · 08-20
减持警报暂解?亿万富翁沃尔特质押Carvana(CVNA.US)股份 空头回补推动股价反弹逾8%
SpaceX解禁后两日暴涨23%,期权成交创纪录,空头回补或进一步推升股价
华尔街见闻 · 08-08
SpaceX解禁后两日暴涨23%,期权成交创纪录,空头回补或进一步推升股价
美股异动 | SpaceX(SPCX.US)涨逾8% 限售股解禁未现抛压 空头回补推动股价上涨
智通财经 · 08-07
美股异动 | SpaceX(SPCX.US)涨逾8% 限售股解禁未现抛压 空头回补推动股价上涨
多家机构判断:中国新能源车空头回补仍将持续
格隆汇 · 08-03
多家机构判断:中国新能源车空头回补仍将持续
花旗:汽车股空头回补料持续 新能源汽车销量明显提升等利好支撑
智通财经 · 08-03
花旗:汽车股空头回补料持续 新能源汽车销量明显提升等利好支撑
加载更多
公司概况
公司名称:
Militia Long/Short Equity ETF
所属市场:
NASDAQ
上市日期:
--
主营业务:
发行价格:
--
{"stockData":{"symbol":"ORR","market":"US","secType":"STK","nameCN":"Militia Long/Short Equity ETF","latestPrice":39.68,"timestamp":1794929683494,"preClose":39.94,"halted":0,"volume":11244,"delay":0,"changeRate":-0.006509764646970406,"floatShares":9100000,"shares":9100000,"eps":0,"marketStatus":"交易中","change":-0.26,"latestTime":"11-17 10:36:35 EST","open":39.715,"high":39.81,"low":39.675,"amount":446967.44016,"amplitude":0.00338,"askPrice":39.77,"askSize":1000,"bidPrice":39.68,"bidSize":900,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1794949200000},"marketStatusCode":2,"adr":0,"exchange":"NASDAQ","adjPreClose":39.94,"sharesOutstanding":12720000,"nav":39.89,"aum":362999000,"bidAskSpread":0,"preHourTrading":{"tag":"盘前","latestPrice":39.93,"preClose":39.94,"latestTime":"07:38 EST","volume":4,"amount":159.72,"timestamp":1794919099678,"change":-0.01,"changeRate":-0.00025,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":39.94,"preClose":39.94,"latestTime":"19:55 EST","volume":434,"amount":17326.8165,"timestamp":1794876903724,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.529321,"impliedVol":0.1153,"impliedVolPercentile":0.289},"requestUrl":"/m/hq/s/ORR","defaultTab":"news","newsList":[{"id":"2684673425","title":"花旗拆解全球股市 “冷热不均”:美股靠空头回补,欧洲迎来实质新多头,亚洲空头获利丰厚","url":"https://stock-news.laohu8.com/highlight/detail?id=2684673425","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2684673425?lang=zh_cn&edition=full","pubTime":"2026-11-17 11:45","pubTimestamp":1794887133,"startTime":"0","endTime":"0","summary":"花旗提示,若美联储预期转鸽或通胀数据走软,或引发大规模空头回补。花旗警告,如果该指数未能守住近期2.5%的反弹幅度,或引发多头清算,进而放大下行势头。此外,DAX指数和富时100指数也受新多头和空头平仓的共同推动而走强。这两个指数的空头规模均处于85%以上的历史分位,且获利丰厚。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1524205.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4207","LU1506573853.SGD","LU2462157665.USD","CGUS","LU0310800965.SGD","LU0098860793.USD","LU1244550577.SGD","BK4534","LU2125154935.USD","LU0072461881.USD","WTLS","LU2456880835.USD","LU0128525689.USD","LU2236285917.USD","IE00BSNM7G36.USD","FTXO","TFNS","ACWI","CLSE","RGLO","BK4566","LU1668664300.SGD","LU1244550221.USD","LU0170899867.USD","LU0980610538.SGD","LU1988902786.USD","LU1267930227.SGD","LU1791807156.HKD","ORR","LU1244550494.USD","LU2360032135.SGD","PRMN","LU0477156953.USD","SHRT","VT","LU1201861249.SGD","IYF","LU0052756011.USD","BK4559","LU0203345920.USD","LU0130517989.USD","BK4588","LU2264538146.SGD","LU0162691827.USD","BK4504","LU1144417596.USD","WSGE","BK4550","LU1064131342.USD","LU0106831901.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2681097581","title":"亚盛医药APG-5918治疗R/R TCL I期数据将在2026 ASH年会口头报告,ORR为44.7%","url":"https://stock-news.laohu8.com/highlight/detail?id=2681097581","media":"同花顺","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2681097581?lang=zh_cn&edition=full","pubTime":"2026-11-05 08:25","pubTimestamp":1793838300,"startTime":"0","endTime":"0","summary":"11月5日,亚盛医药(06855.HK)集团宣布,公司多项临床和临床前研究进展入选第68届美国血液学会(ASH)年会,涉及奥雷巴替尼、利沙托克拉、APG-5918和APG-3288四个品种。第68届ASH年会将于当地 ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tonghuashun_highlight","url":"http://news.10jqka.com.cn/20261105/c681483113.shtml","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://news.10jqka.com.cn/20261105/c681483113.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun_highlight","symbols":["ORR","150130"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679516216","title":"瑞银预计英镑年底升至1.38美元,英国加息预期及空头回补提供支撑","url":"https://stock-news.laohu8.com/highlight/detail?id=2679516216","media":"环球市场播报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679516216?lang=zh_cn&edition=full","pubTime":"2026-10-30 19:46","pubTimestamp":1793360760,"startTime":"0","endTime":"0","summary":"10月30日,瑞银集团预计,英镑兑美元汇率将在今年12月升至1.38,2027年3月进一步升至1.39,并在2027年下半年达到1.41。截至北京时间30日19时38分,英镑兑美元上涨0.4%,报1.3430,创10月以来新高,有望连续第三周上涨。货币政策方面,瑞银预计英国央行将从下周开始新一轮加息,并于2027年第一季度进一步提高利率。不过,瑞银指出,若美国经济表现强于预期,或美联储加息次数超过该行预测,英镑上涨空间可能受到限制。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-10-30/doc-iniwziiq2190875.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["UDN","UUP","TLT","ORR","US2Y.BOND","WTLS","SHRT","US6M.BOND","US12M.BOND","US10Y.BOND","PRMN","CLSE","TLTW","US5Y.BOND","MGBPmain","GBPmain","TMF","US30Y.BOND","FXB","US7Y.BOND","US3Y.BOND"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679657912","title":"TIL 赛道首款国产产品闯关 君赛生物诺吉仑赛注射液商业化前景几何?","url":"https://stock-news.laohu8.com/highlight/detail?id=2679657912","media":"新浪证券","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679657912?lang=zh_cn&edition=full","pubTime":"2026-10-30 13:53","pubTimestamp":1793339580,"startTime":"0","endTime":"0","summary":"近日,君赛生物宣布诺吉仑赛注射液新药上市申请已获中国国家药品监督管理局受理,和信迪利单抗注射液用于既往接受过至少两种系统治疗失败的不可切除或转移性黑色素瘤患者。剔除重叠人群后,诺吉仑赛的国内年新增潜在目标患者总人数约 5400 人。结合 0.90 的临床成功概率,最终诺吉仑赛注射液黑色素瘤适应症的风险调整净现值约为 1.7 亿元。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/observe/2026-10-30/doc-iniwysmx8242185.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["IPOS","BK4159","BK4195","PFS","BK4211","RCT","ORR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678149129","title":"九大研究贯通两大板块:艾帕洛利托沃瑞利单抗以全病程布局回应消化道肿瘤之困","url":"https://stock-news.laohu8.com/highlight/detail?id=2678149129","media":"同花顺","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678149129?lang=zh_cn&edition=full","pubTime":"2026-10-27 16:13","pubTimestamp":1793088780,"startTime":"0","endTime":"0","summary":" 编者按:2026年欧洲肿瘤内科学会(ESMO)年会于10月23日至27日在西班牙马德里召开,作为全球肿瘤领域最具影响力的学术盛会之一,ESMO始终聚焦前沿诊疗进展,引领临床实践变革方向。本届年会 ...","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tonghuashun_highlight","url":"http://news.10jqka.com.cn/20261027/c681134750.shtml","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://news.10jqka.com.cn/20261027/c681134750.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun_highlight","symbols":["BTCC","CBOO","XBTY","CBXA","CBOJ","CBXO","SD","BITY","NETL","BTCO","BITU","CBXJ","IBIT","BAGY","BTCI","BPI","BTCW","CR","BITX","FBTC","BCCC","ORR","BITO","PR","PFS","BTF","CBXY","MAXI","BETH","BTRN","HPE","CBOA","GBTC","MSS","MNRS","CBTY","HODL","CBTJ","BFAP","BTC","PXI","YBTC","CBOY","ADC","BFJL","L","HPEL","FXN","BTCL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678673061","title":"泽璟制药:2026年ESMO年会ZG006确认ORR最高91.7%","url":"https://stock-news.laohu8.com/highlight/detail?id=2678673061","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678673061?lang=zh_cn&edition=full","pubTime":"2026-10-26 19:05","pubTimestamp":1793012737,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["ORR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677276908","title":"CLDN18.2靶向ADC 3期研究达到双主要终点;双靶点ADC 3期结果积极……","url":"https://stock-news.laohu8.com/highlight/detail?id=2677276908","media":"同花顺","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2677276908?lang=zh_cn&edition=full","pubTime":"2026-10-24 07:35","pubTimestamp":1792798500,"startTime":"0","endTime":"0","summary":" CLDN18.2靶向ADC国际3期研究达到双主要终点,延长胃癌患者PFS和OS 武田(Takeda)和信达生物(Innovent Biologics)公布了在研CLDN18.2靶向抗体偶联药物(ADC)arcotatug tava ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tonghuashun_highlight","url":"http://news.10jqka.com.cn/20261024/c681047440.shtml","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://news.10jqka.com.cn/20261024/c681047440.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun_highlight","symbols":["LU0237698245.USD","LU1571399168.USD","LU1430594728.SGD","BK4195","LU1868837136.USD","BMY","BK4139","LU0061475181.USD","BK4581","LU0306806265.USD","IE00BFTCPJ56.SGD","ADC","BK4559","BK4585","ITT","LU0114720955.EUR","IE0009355771.USD","IHE","LU1032466523.USD","FFBC","LU1291159041.SGD","LU2596442595.SGD","BK4231","GMAB","FTXH","LU2360032135.SGD","LU0456855351.SGD","LU1236620750.USD","IE00BFXG1179.USD","LU1670711040.USD","LU1670710661.SGD","BK4211","LU0321505868.SGD","BK4532","LU2133065610.SGD","LU0985481810.HKD","NETL","LU1261432733.SGD","BK4534","LU2125154935.USD","LU0096364046.USD","PFS","LU0432979614.USD","IE00BSNM7G36.USD","LU1983299246.USD","ORR","LU1074936037.SGD","LU1670711123.USD","LU2242646821.SGD","LU0225284248.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677979202","title":"原油盘中涨近4%,布油冲上117美元,中东风险持续、空头回补加把火","url":"https://stock-news.laohu8.com/highlight/detail?id=2677979202","media":"华尔街见闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2677979202?lang=zh_cn&edition=full","pubTime":"2026-10-24 01:14","pubTimestamp":1792775671,"startTime":"0","endTime":"0","summary":"中东能源供应风险持续升温,叠加周末前空头回补及期权对冲买盘,国际原油进一步走高。美东时间23日周五美股早盘时段,美国WTI原油一度逼近103.30美元/桶,日内涨幅超过3.8%;布伦特原油一度突破117.40美元/桶,日内涨近3.8%。布油年内累计涨幅已超过85%,中东冲突引发的供应风险溢价仍是支撑油价的重要力量。","market":"us","thumbnail":"https://static.tigerbbs.com/90b557d4f9e36e20bc3bd3ba410e27e5","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/90b557d4f9e36e20bc3bd3ba410e27e5"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://wallstreetcn.com/articles/3784356","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["QMmain","USO","USOI","DBC","PXJ","XES","DRLL","FTXN","SCO","IEO","DRIP","BK4585","DUG","PRMN","WTIU","FLBR","WTLS","BZmain","FBZ","PXE","UGA","GUSH","UDN","FAAR","CLmain","OILK","UUP","DIG","USE","OIH","IXC","UCO","ERX","OILT","USL","BNO","DBO","DDG","BK4588","XOP","DWT","SHRT","VDE","BK4570","DBE","ORR","CLSE","OILU","MCLmain"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2675591106","title":"德银:黄金量化抛压接近“绝对耗尽”,CTA空头回补或点燃Q4反弹行情","url":"https://stock-news.laohu8.com/highlight/detail?id=2675591106","media":"华尔街见闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675591106?lang=zh_cn&edition=full","pubTime":"2026-10-16 19:40","pubTimestamp":1792150858,"startTime":"0","endTime":"0","summary":"德银认为,量化基金风险平价组合去杠杆规模已达2010年以来第90百分位,黄金算法卖盘接近\"绝对耗尽\",CTA空头回补或形成自我强化的买入循环,支撑四季度金价走强。不过,金价仍需突破约4370美元/盎司才能触发新一轮大规模程序化买入。","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://wallstreetcn.com/articles/3783795","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["JPFP","TFPN","DUST","DULL","GBUG","GCmain","AAAU","SDMF","UYM","SGDM","02840","FGDL","MGCmain","DBMF","BTGD","ORR","WTLS","DGP","IAUI","159831","PRMN","IAUM","GDXD","OUNZ","DZZ","GDXU","IAU","GLTR","JDST","GDXJ","ISMF","GOAU","BAR","GOLY","GDX","PALL","1OZmain","PICK","BEGS","DBC","CLSE","XME","USG","JNUG","SGOL","GLL","PHYS","UGL","GDXY","FAAR"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2675732483","title":"劲方医药-B(02595.HK):GFH375/VS-7375多项国内及海外临床研究取得积极进展,在多种 RAS 突变实体瘤中显示优秀疗效","url":"https://stock-news.laohu8.com/highlight/detail?id=2675732483","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675732483?lang=zh_cn&edition=full","pubTime":"2026-10-15 08:02","pubTimestamp":1792022533,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4195","PFS","BK4211","ORR","BK4213","CRC","LU0456854461.SGD","LU0266512127.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669116157","title":"交易员:布雷曼讲话引发空头回补,纽元兑美元上涨","url":"https://stock-news.laohu8.com/highlight/detail?id=2669116157","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669116157?lang=zh_cn&edition=full","pubTime":"2026-09-22 14:11","pubTimestamp":1790057471,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["CLSE","WTLS","UDN","PRMN","SHRT","ORR","UUP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669515363","title":"EGFR ex20ins赛道进入冲刺赛:伏美替尼申报一线适应症 国产双药同台竞技","url":"https://stock-news.laohu8.com/highlight/detail?id=2669515363","media":"新浪证券","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669515363?lang=zh_cn&edition=full","pubTime":"2026-09-21 15:19","pubTimestamp":1789975140,"startTime":"0","endTime":"0","summary":"迪哲医药的舒沃替尼、艾力斯的伏美替尼两大国产明星靶向药相继突破,国内EGFR ex20ins治疗格局有望改写。伏美替尼入局20ins一线审批国产双药同台竞技创新药赛道的竞争,本质是时间的竞争。依托WU-KONG28研究的重磅阳性结果,舒沃替尼一线EGFR ex20ins适应症上市申请于2026年5月正式获NMPA受理,并同步纳入优先审评程序。整体来看,2026年底至2027年,国内EGFR ex20ins一线赛道或将迎来双药集中获批的关键窗口期。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/observe/2026-09-21/doc-inisqkzy8948524.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["IPOS","BK4195","PFS","BK4211","ORR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667658657","title":"港股异动 | 映恩生物-B涨超9%,DB-1311联用Pumitamig WCLC摘要披露,一线SCLC ORR达92.3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2667658657","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667658657?lang=zh_cn&edition=full","pubTime":"2026-09-14 14:38","pubTimestamp":1789367907,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,映恩生物-B涨超9%,截至发稿,涨8.48%,报183港元,成交额1.65亿港元。消息面上,世界肺癌大会更新了映恩生物与BioNTech共同开发的B7-H3 ADC BNT324/DB-1311联合PD-L1×VEGF-A双抗Pumitamig治疗晚期肺癌的Ib/II期数据:截至2026年7月7日,71例可评估小细胞肺癌患者整体客观缓解率为70.4%,其中一线92.3%、二线77.3%、三线及以上52.4%。","market":"hk","thumbnail":"https://community-static.tradeup.com/news/b772ac54294987140db862d7556db12e","type":0,"news_type":0,"thumbnails":["https://community-static.tradeup.com/news/b772ac54294987140db862d7556db12e"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1495543.html","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":"映恩生物 DB-1311联用Pumitamig WCLC摘要披露,一线SCLC ORR达92.3%","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["HK0000252152.HKD","BK1161","09606","KCAI","HK0000500386.USD","BK4588","LU2543165471.USD","ORR","HK0000252160.HKD","VXUS","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666798529","title":"创新药将迎数据催化窗口!OS、PFS、ORR还都分不清楚?速查指南来了!收藏备用","url":"https://stock-news.laohu8.com/highlight/detail?id=2666798529","media":"新浪基金","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666798529?lang=zh_cn&edition=full","pubTime":"2026-09-11 19:22","pubTimestamp":1789125720,"startTime":"0","endTime":"0","summary":"创新药重磅提示!就在周六,2026年WCLC将正式开幕,康方生物、石药集团、科伦博泰生物等诸多创新药龙头公司将公布旗下核心产品临床数据。III期达到终点,意味着获批概率大幅提升,属于实质性大利好。临床试验中通常报告“中位OS”,即50%患者存活的时间。FDA加速批准程序允许基于替代终点批准药物,但上市后需完成确证性试验。FDA规定,提交后30天内若无异议,IND自动生效。以优效性为目标的头对头试验证据级别最高。权重数据截至2026.8.31。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/money/fund/etf/2026-09-11/doc-inirnhrw8907408.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1161","06978","LNGR","159992","MEDX","IBBQ","ORR","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666583697","title":"迪哲医药:比瑞替尼II期研究发表,ORR达47.6%","url":"https://stock-news.laohu8.com/highlight/detail?id=2666583697","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666583697?lang=zh_cn&edition=full","pubTime":"2026-09-09 15:48","pubTimestamp":1788940107,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["ORR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660047782","title":"减持警报暂解?亿万富翁沃尔特质押Carvana(CVNA.US)股份 空头回补推动股价反弹逾8%","url":"https://stock-news.laohu8.com/highlight/detail?id=2660047782","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660047782?lang=zh_cn&edition=full","pubTime":"2026-08-20 10:06","pubTimestamp":1787191592,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["WTLS","SHRT","CVNA","BK4503","CLSE","CVNX","CVNY","LU0133085943.USD","BK4214","BK4548","LU0175139822.USD","CLIX","PRMN","ORR","IE00BD6J9T35.USD","BK4585","LU0289960550.SGD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657280621","title":"SpaceX解禁后两日暴涨23%,期权成交创纪录,空头回补或进一步推升股价","url":"https://stock-news.laohu8.com/highlight/detail?id=2657280621","media":"华尔街见闻","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657280621?lang=zh_cn&edition=full","pubTime":"2026-08-08 06:48","pubTimestamp":1786142899,"startTime":"0","endTime":"0","summary":"SpaceX两日市值激增3270亿美元,股价重新逼近135美元IPO发行价。周五截至纽约时间下午1时50分,SpaceX期权成交量达到224万份合约,其中看涨期权成交量达到130万份,创历史新高。目前仍有超过2.5亿股SpaceX股票被卖空,股价快速上涨,空头被迫回补可能进一步推升股价。","market":"other","thumbnail":"https://static.tigerbbs.com/f16a7a67d0d2e6f1e72c43b8fe10d226","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/f16a7a67d0d2e6f1e72c43b8fe10d226"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"6c5b1e98ab57449e9a363569b6b7313b","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://wallstreetcn.com/articles/3778979","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":"SpaceX解禁后两日暴涨23%,期权成交创纪录,空头回补或进一步推升股价","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SSPC","BK4615","LU1861558580.USD","LU1861215975.USD","SPAX","LU1861220033.SGD","WSPC","MARS","LU1861559042.SGD","UFO","SPAL","BK4089","PRMN","SPCU","SPCX","CLSE","ORR","DXYZ","SHRT","SPCQ","WTLS","SPCM","SPCF","SNK","LOFF","XOVR","LU2360107168.USD","ORBX","LU2290526834.HKD","WARP","SPCH","SPCG"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2657644945","title":"美股异动 | SpaceX(SPCX.US)涨逾8% 限售股解禁未现抛压 空头回补推动股价上涨","url":"https://stock-news.laohu8.com/highlight/detail?id=2657644945","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657644945?lang=zh_cn&edition=full","pubTime":"2026-08-07 22:26","pubTimestamp":1786112794,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["PRMN","LOFF","SPCH","LU1861559042.SGD","LU2290526834.HKD","MARS","SSPC","SPCU","XOVR","LU1861558580.USD","SPAX","SPCG","WARP","LU1861220033.SGD","WTLS","SPCM","WSPC","SPAL","ORBX","UFO","SPCF","LU2360107168.USD","SPCX","BK4615","SHRT","DXYZ","ORR","LU1861215975.USD","SPCQ","BK4089","SNK","CLSE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656634286","title":"多家机构判断:中国新能源车空头回补仍将持续","url":"https://stock-news.laohu8.com/highlight/detail?id=2656634286","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2656634286?lang=zh_cn&edition=full","pubTime":"2026-08-03 10:55","pubTimestamp":1785725750,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["ORR","WTLS","CLSE","SHRT","PRMN","KBA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656566349","title":"花旗:汽车股空头回补料持续 新能源汽车销量明显提升等利好支撑","url":"https://stock-news.laohu8.com/highlight/detail?id=2656566349","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2656566349?lang=zh_cn&edition=full","pubTime":"2026-08-03 08:39","pubTimestamp":1785717558,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU1506573853.SGD","LU2125154935.USD","LU0106831901.USD","PRMN","LU2236285917.USD","LU0203347892.USD","BK4566","LU0314106906.USD","FTXO","LU0128525689.USD","LU0980610538.SGD","LU0098860793.USD","LU1267930227.SGD","LU1244550494.USD","IE00BSNM7G36.USD","LU2125154778.USD","LU0170899867.USD","BK4585","LU2417539215.USD","LU0072461881.USD","LU0203345920.USD","WTLS","LU0162691827.USD","BK4534","LU2456880835.USD","LU1201861249.SGD","LU2462157665.USD","FDIS","IYF","LU1791807156.HKD","SHRT","LU1244550577.SGD","LU0648001328.SGD","LU0320765646.SGD","CLSE","LU1074936037.SGD","CARU","BK4504","LU0477156953.USD","LU1162221912.USD","BK4207","LU1366192091.USD","BK4559","LU0130517989.USD","TFNS","LU1244550221.USD","LU0310800965.SGD","LU2360032135.SGD","ORR","LU0052756011.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"stockEarnings":[{"period":"1week","weight":0.0071},{"period":"1month","weight":0.0294},{"period":"3month","weight":0.0577},{"period":"6month","weight":0.0868},{"period":"1year","weight":0.2118},{"period":"ytd","weight":0.1692}],"compareEarnings":[{"period":"1week","weight":-0.0169},{"period":"1month","weight":-0.0305},{"period":"3month","weight":-0.0358},{"period":"6month","weight":-0.0018},{"period":"1year","weight":0.1012},{"period":"ytd","weight":0.0851}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"exchange":"NASDAQ","name":"Militia Long/Short Equity ETF","nameEN":"Militia Long/Short Equity ETF"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.54.0","shortVersion":"4.54.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Militia Long/Short Equity ETF(ORR)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Militia Long/Short Equity ETF(ORR)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Militia Long/Short Equity ETF,ORR,Militia Long/Short Equity ETF股票,Militia Long/Short Equity ETF股票老虎,Militia Long/Short Equity ETF股票老虎国际,Militia Long/Short Equity ETF行情,Militia Long/Short Equity ETF股票行情,Militia Long/Short Equity ETF股价,Militia Long/Short Equity ETF股市,Militia Long/Short Equity ETF股票价格,Militia Long/Short Equity ETF股票交易,Militia Long/Short Equity ETF股票购买,Militia Long/Short Equity ETF股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Militia Long/Short Equity ETF(ORR)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Militia Long/Short Equity ETF(ORR)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}